Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.

Rintaro NoroKunihiko KobayashiJiro UsukiMakiko YomotaMasaru NishitsujiTsuneo ShimokawaMasahiro AndoMitsunori HinoKoichi HagiwaraAkihiko MiyanagaMasahiro SeikeKaoru KubotaAkihiko Gemmanull null

Published in: Thoracic cancer (2020)

UMIN000006868 was a phase II study of efficacy of bevacizumab plus chemotherapy for the management of malignant pleural effusion (MPE) in nonsquamous non-small cell lung cancer patients with MPE unsuccessfully controlled by tube drainage or pleurodesis (North East Japan Study Group Trial NEJ-013B) (http://umin.sc.jp/ctr/).

Keyphrases

phase ii study
locally advanced
open label
clinical trial
phase iii
study protocol
rectal cancer
phase ii
squamous cell carcinoma
randomized controlled trial
ultrasound guided
radiation therapy
metastatic colorectal cancer
double blind